Pfizer CEO Albert Bourla received $24.6 million in total compensation ... One month later, the company discontinued a Phase 3 hemophilia A gene therapy from its Spark Therapeutics unit and said its ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Earlier this month, Pfizer CEO Albert Bourla, Ph.D., also acknowledged that the large volume of drugs means additional tariffs would be challenging for the industry to manage. But he also said the ...

CEOs including Apple’s Tim Cook, FedEx’s Raj Subramaniam and Pfizer’s Albert Bourla gathered in the Chinese capital over the weekend for a two-day forum that comes as US President Donald ...

Eli Lilly’s acquisition of gene therapy specialist Akouos seems to have paid off, after the lead candidate in the deal restored hearing in a child with congenital deafness. The AK-OTOF therapy ...

Ten out of 11 children with a form of congenital deafness who were treated with an experimental gene therapy developed by Regeneron have seen notable improvements in hearing, according to new data ...

Gene regulation refers to the mechanisms that act to induce or repress the expression of a gene. These include structural and chemical changes to the genetic material, binding of proteins to ...

What do you notice about the mass of biological (living) forms and mass of technological (man-made) forms on Earth? What do you wonder? By The Learning Network A teenager and a New York Times ...

Among those in attendance were Merck CEO Robert Davis, Pfizer CEO Albert Bourla and Eli Lilly CEO David Ricks. Two of these executives have since signed off on hefty investments into their U.S.

Pfizer’s CEO, Albert Bourla, stated at the TD Cowen Healthcare Conference on 3 March that if tariffs came into play, “we will try to mitigate by transferring from manufacturing sites outside to ...

as there was no uniform standard of reliable methods for the clear characterization of these starting points for the ribosome-mediated control of gene expression. Researchers have now ...